Literature DB >> 12740470

Multidetector CT of peritoneal carcinomatosis from ovarian cancer.

Harpreet K Pannu1, Robert E Bristow, Frederick J Montz, Elliot K Fishman.   

Abstract

Ovarian cancer is usually in an advanced stage at diagnosis due to the presence of peritoneal carcinomatosis, which develops as a result of peritoneal fluid circulation. Tumor implants of varying size can occur anywhere from the diaphragm through the pelvis. Computed tomography (CT) can be used to detect these metastatic lesions, which can be miliary or large and appear as soft-tissue or low-attenuation masses. Recent advances in CT technology have increased the flexibility of image acquisition, thereby allowing the use of thin sections and multiplanar reformatting. With multidetector CT, thin-section images of the abdomen and pelvis can be obtained to assess for subcentimeter implants and to create three-dimensional images with reduced artifact. Multiplanar reformatting can be used to confirm the presence of implants. Structures such as the diaphragm, paracolic gutters, bowel, and cul-de-sac can be evaluated in multiple planes for surface nodularity and small implants. Interactive multiplanar review of the abdomen and pelvis has the potential to improve detection of peritoneal metastases at CT.

Entities:  

Mesh:

Year:  2003        PMID: 12740470     DOI: 10.1148/rg.233025105

Source DB:  PubMed          Journal:  Radiographics        ISSN: 0271-5333            Impact factor:   5.333


  31 in total

1.  Pre-operative evaluation of peritoneal deposits using multidetector computed tomography in ovarian cancer.

Authors:  S H Chandrashekhara; S Thulkar; D N Srivastava; L Kumar; R Hariprasad; S Kumar; M C Sharma
Journal:  Br J Radiol       Date:  2010-09-21       Impact factor: 3.039

Review 2.  ESUR guidelines: ovarian cancer staging and follow-up.

Authors:  Rosemarie Forstner; Evis Sala; Karen Kinkel; John A Spencer
Journal:  Eur Radiol       Date:  2010-09-14       Impact factor: 5.315

3.  Peritoneal sarcoidosis: the role of imaging in diagnosis.

Authors:  Meghan G Lubner; Perry J Pickhardt
Journal:  Gastroenterol Hepatol (N Y)       Date:  2009-12

4.  Comparative evaluation of multidetector CT and MR imaging in the differentiation of adnexal masses.

Authors:  A C Tsili; C Tsampoulas; M Argyropoulou; I Navrozoglou; Y Alamanos; E Paraskevaidis; S C Efremidis
Journal:  Eur Radiol       Date:  2008-01-10       Impact factor: 5.315

Review 5.  Imaging of peritoneal deposits in ovarian cancer: A pictorial review.

Authors:  Sheragaru Hanumanthappa Chandrashekhara; Gowramma Sannanaik Triveni; Rahul Kumar
Journal:  World J Radiol       Date:  2016-05-28

6.  Whole-body MRI with diffusion-weighted sequence for staging of patients with suspected ovarian cancer: a clinical feasibility study in comparison to CT and FDG-PET/CT.

Authors:  Katrijn Michielsen; Ignace Vergote; Katya Op de Beeck; Frederic Amant; Karin Leunen; Philippe Moerman; Christophe Deroose; Geert Souverijns; Steven Dymarkowski; Frederik De Keyzer; Vincent Vandecaveye
Journal:  Eur Radiol       Date:  2013-12-11       Impact factor: 5.315

7.  CCL2 secreted from cancer-associated mesothelial cells promotes peritoneal metastasis of ovarian cancer cells through the P38-MAPK pathway.

Authors:  Hiroaki Yasui; Hiroaki Kajiyama; Satoshi Tamauchi; Shiro Suzuki; Yang Peng; Nobuhisa Yoshikawa; Mai Sugiyama; Kae Nakamura; Fumitaka Kikkawa
Journal:  Clin Exp Metastasis       Date:  2019-09-21       Impact factor: 5.150

Review 8.  PET/CT and cross sectional imaging of gynecologic malignancy.

Authors:  Revathy B Iyer; Aparna Balachandran; Catherine E Devine
Journal:  Cancer Imaging       Date:  2007-10-01       Impact factor: 3.909

Review 9.  Endodermal sinus tumor: a rare cause of calcified peritoneal implants.

Authors:  Anupam Lal; Hina Arif Mumtaz; S Radhika; Niranjan Khandelwal
Journal:  Cancer Imaging       Date:  2009-06-15       Impact factor: 3.909

10.  Pathways of abdominal tumour spread: the role of the subperitoneal space.

Authors:  Richard M Gore; Geraldine M Newmark; Kiran H Thakrar; Uday K Mehta; Jonathan W Berlin
Journal:  Cancer Imaging       Date:  2009-12-24       Impact factor: 3.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.